Scenario: 2022 TURB [my registry software has also had the 2022 upgrade applied]
Question: How would you code histology?
- 8120/2 Urothelial carcinoma in situ
- 8130/2 Urothelial carcinoma, papillary, non-invasive (C67._)
Answer: 8130/2 Urothelial carcinoma, papillary, non-invasive (C67._)
September 2021 Revision History for the Solid Tumor Rules https://seer.cancer.gov/tools/solidtumor/revisions.html
AskSEERCtr: From: AskSEERCTR <askseerctr@imsweb.com>
Sent: Friday, November 19, 2021 1:41 PM
Cc: AskSEERCTR <askseerctr@imsweb.com>
Subject: (External Mail) RE: Ask SEER CTR #30495
The change applies to cases diagnosed 1/1/2022 forward. At the request of the AJCC Urinary experts, we changed the instructions to allow configuration to be used to code histology. Don’t confuse previous instructions with the 2022 changes.
The page for Solid tumor Rules notes the following in the blue box at the top of the page:
The September 2021 Update includes changes that apply to cases diagnosed January 1, 2022 and after. The editors recommend that until these changes are implemented, registrars continue using the current Solid Tumor Rules (PDF, 7.0 MB), updated December 2020, for cases diagnosed from January 1, 2018 through 12/31/2021.